9.40Open9.40Pre Close2 Volume0 Open Interest68.00Strike Price1.88KTurnover2613.68%IV0.27%PremiumDec 13, 2024Expiry Date9.19Intrinsic Value100Multiplier0DDays to Expiry0.21Extrinsic Value100Contract SizeAmericanOptions Type0.9958Delta0.0033Gamma8.44Leverage Ratio-15.8575Theta0.0000Rho8.40Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet